GNRH1 and polycystic ovary syndrome: The PCOS group had greater baroreflex gain under GnRH antagonism, which returned to control levels with the addition of exogenous testosterone, whereas the same procedures did not affect sympathetic baroreflex gain in controls (Stone et al., 2023).